Organon (OGN) Invested Capital (2020 - 2026)

Organon (OGN) has reported Invested Capital for 7 consecutive years, with $9.5 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Invested Capital changed 0.27% year-over-year to $9.5 billion; the TTM figure through Mar 2026 stood at $9.5 billion (changed 0.27% YoY), while the FY2025 annual figure was $9.4 billion, changed 0.47% from the prior year.
• Invested Capital came in at $9.5 billion for Q1 2026 at Organon, up from $9.4 billion in the prior quarter.
• The five-year high for Invested Capital was $9.7 billion in Q3 2025, with the low at $7.6 billion in Q3 2022.
• Average Invested Capital over 5 years is $8.7 billion, with a median of $8.8 billion recorded in 2024.
• The largest YoY upside for Invested Capital was 25.76% in 2022 against a maximum downside of 0.64% in 2022.
• Year by year, Invested Capital stood at $8.0 billion in 2022, then increased by 8.34% to $8.7 billion in 2023, then advanced by 7.62% to $9.4 billion in 2024, then gained by 0.47% to $9.4 billion in 2025, then climbed by 0.81% to $9.5 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $9.5 billion, $9.4 billion, and $9.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.